Psyadon Pharmaceuticals psyadonrx.com


Public list: Smart Money VCs (6327) Pharma Startups (4729)

Psaydon Pharmaceuticals, formerly Ruxton Pharmaceuticals, is developing drugs to treat neurodegenerative diseases with an initial focus on glutamate transporters for ALS

Psaydon Pharmaceuticals, formerly Ruxton Pharmaceuticals, is developing drugs to treat neurodegenerative diseases with an initial focus on glutamate transporters for ALS

Company (Alive / Active)

Phone: 301-919-2020

Fax:

20451 Seneca Meadows Parkway

Germantown, 20876
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Psyadon Pharmaceuticals $13.2M Nov 5, 2008

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Psyadon Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
New Enterprise AssociatesVenture CapitalMenlo Park, California, United StatesUnattributed VC, Series A
Domain AssociatesVenture CapitalPrinceton, New Jersey, United StatesUnattributed VC, Series A
Aberdare VenturesVenture CapitalSan Francisco, California, United StatesUnattributed VC, Series A
See all 3 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Fused benzazepines for treatment of stuttering Oct 17, 2014 Application
Fused benzazepines for treatment of tourette's syndrome Jul 12, 2013 Application